Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

622

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2032

Conditions

Breast CancerRadiotherapy; Complications

Interventions

RADIATION

Hypofractionation

Radiation regimen of 2.5-3.0Gy x 13-17 fractions +/- sequential boost 0-7 fractions

RADIATION

Conventional Fractionation

Radiation regimen of 1.8-2.0Gy x 23-28 fractions +/- sequential boost 0-5 fractions

All Listed Sponsors

collaborator

Seoul National University Hospital

OTHER

lead

Seoul National University Bundang Hospital

OTHER

NCT05253170 - Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients | Biotech Hunter | Biotech Hunter